Bcl-2/Bcl-xL/Mcl-1 inhibitors (Evotec)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameBcl-2/Bcl-xL/Mcl-1 inhibitors (Evotec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator Bcl-X inhibitorsInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors
TargetsApoptosis regulator Bcl-XInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvotec SE
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A